- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
Jumping in at a near 52-week low. Low debt has me sold. Hopefully they can make something happen. 5% yield ain't bad either.
Recs
China's premier drug store company. Ride this bubble and make some quick cash.
Recs
NPD just keeps expanding and this is when the stock makes a good investment.
Recs
Don't fight the flow, China's the only thing going up right now.
Recs
Its China, great company.
Recs
This is a tough company in terms of getting accurate information and/or news. I own about 1500 shares around the 5.00 mark and tomorrow is earnings report. Although past press and sentiment has been somewhat negative the press and reports I have read talk about new management. Looking at their resumes and track records, collectively (on the surface) they appear like a strong team. Can they play nice and stay on the same page? If so I think the stock price will reach 6.50 or so by spring of 2010 and 7 - 10.00 by 2012. It seems to me being a company with little debt in an expanding economy is a set up for a little growth and longer term value.
Recs
I will throw a grand at this one and hope for the best. If all goes well I will be much wealthier in a few years. Wish me luck.
Recs
Oversold....
Recs
Ready to roll on this one. This and many other Chinese stocks are way oversold right now and this guy has no debt and high income. Also is the major player in the drug market of China. I look for a big gain when the market stabilizes.
Recs
Earnings are 9.5 times revenue. It's all about Debt this season and this drugstore chain has....NONE! Definite buy at this price.
Recs
www.allthingspersonalfinance.blogspot.com
Recs
Significantly undervalued.
Recs
Recs
Evilucius pick. Outperform.
Recs
A long-term play on the healthcare market in China
Recs
A little bit concern about Goldman Sachs' command on this company to accelerate short term growth and a better quarterly earning report. But overall the company's business model is very successful in China.
Recs
China stocks are growing in value as the services rendered for the immense Chinese population grows. Healthcare in China is a mixture of traditional and western practices, and China Nepstar (the largest drugstore chain in mainland China) focuses on both these treatment modalities. As a Pharmacist who has spent extensive time in China, I see the future growth in this field as both necessary and logical. China is the biggest untapped market in world finance and will continue to be so for at least the next decade.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 21 - 37 of 37 : « Previous 1 2